Robert Azelby Insider Trading $CLVS Clovis Oncology, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Azelby.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Azelby. Robert Azelby is Director in IMMUNOMEDICS INC ($IMMU) and Director in Cascadian Therapeutics, Inc. ($CASC) and President and CEO in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in Clovis Oncology, Inc. ($CLVS) and EVP & Chief Commercial Officer in Juno Therapeutics, Inc. ($JUNO) and See Remarks in Juno Therapeutics, Inc. ($JUNO).
Robert Azelby in Clovis Oncology, Inc.
Trading Symbol: CLVSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Azelby: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2021
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robert Azelby in Clovis Oncology, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDR, CASC, CLVS, IMMU, JUNO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 5.97 | 42,223 | 252,071 | 42,223 | |
Jun 05 2020 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
Jun 07 2019 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
Jun 07 2019 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
Oct 15 2018 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 27.92 | 25,848 | 721,676 | 25,848 | |
Oct 15 2018 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 27.92 | 25,848 | 721,676 | 25,848 |
Page: 1